Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Referred to as a “selective CB2 agonist,” such a compound would appear to have potential as a treatment […]
Project CBD speaks with Matt Elmes, PhD, director of new product development at CannaCraft, about his post-doctoral research on CBD, fatty acid transport molecules, and the endocannabinoid system.
In recent years, cannabis has been at the center of one of the most important developments in modern science – significantly advancing our understanding of health and disease.
Rather than banning an entire product category – be it vapes or edibles – state health officials should implement a rigorous regulatory program that prioritizes public health and raises the safety standards for all edibles and food supplements.
Democratic Gov. Jay Inslee of Washington directed health officials on Friday to ban the sale of all flavored e-cigarettes and vaping products in the state. In an executive order, the governor called on the state Board of Health to issue the ban, which is to include both nicotine and THC-based products, at its meeting scheduled […]
The discovery could pave the way for a new treatment which would save patients from the risk of addiction problems. Researchers have uncovered how cannabis plants produce a pain-relieving molecule which is 30 times more powerful than aspirin at reducing inflammation. The discovery could pave the way to developing a new medicine derived from the […]
If you’ve been following current events in the world of cannabis (or if you’ve just been a little observant), you probably have noticed the ever-recognizable green serrated leaf advertised all… The post CBD vs. THC: Friends or Foes? appeared first on MedicalMarijuanaBlog.com.